News Newsletter R&I

Two new case studies released by the future Partnership on Health Innovation

Posted on 09.12.2020

Within the framework of the proposed European Health Innovation Public-Private Partnership (PPP) under Horizon Europe, five industry associations representing the pharmaceutical, biotech and medical technologies industries operating in Europe (COCIR, EFPIA, MedTech Europe, EuropaBio and Vaccines Europe) have come together to illustrate how such partnership can address pressing healthcare challenges in several disease areas. The partners have jointly released two new case studies, visualizing the opportunities along the patient journey in Anti-microbial resistance (AMR) and Chronic obstructive pulmonary disease (COPD). Earlier this year, we released four more case studies, picturing the cross-sectoral research and innovation prospects in Breast Cancer, Asthma, Obesity and Chronic Back Pain.

These examples illustrate areas of action as outlined in the Strategic Research Agenda but do not express a commitment to future projects, nor exclude other potential activities to address major challenges in these disease areas. Find more information at the interim joint website of the Partnership.